drugset / Trial / NCT07668518

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

NCT07668518 ↗

Phase 1/2 Not yet recruiting 36 enrolled Kither Biotech Srl Avance Clinical Pty Ltd. · collab
RandomizedSequentialDouble-blindTreatment

Summary

Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.

Timeline

Start
2026-07-01
Primary completion
2027-03-31
Completion
2027-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject KIT2014 Unknown — Other